Halozyme Therapeutics, Inc. (HALO): 8-K filed Sep 22, 2026

Form type

8-K

Filing date

Sep 22, 2026

Accession number

0001193125-26-398015

Filer

Halozyme Therapeutics, Inc. (CIK 1159036)